Selank 10 MG

$80.00

Elite-tier peptide powerhouse revolutionizing the scientific study of anxiety modulation, cognitive clarity, and stress resilience. Masterfully engineered to bridge the gap between immune function and brain vitality, this innovative heptapeptide naturally boosts BDNF levels and protects endogenous endorphins without ever causing sedation, brain fog, or unwanted dependency. Whether you are developing cutting-edge models of neuroplasticity or exploring advanced solutions for cognitive optimization, our ultra-pure, HPLC-verified Selank guarantees unrivaled laboratory precision and premium consistency for your most visionary discoveries.

10 MG

Per vial

Lyophilized Powder

Form

99.1%

Purity

Property

Value

CAS #

129954-34-3

Molecular Formula

C₃₃H₅₇N₁₁O₉

Molecular Weight

~751.89 g/mol

Half-life

Approximately 2–10 minutes in systemic plasma (rapidly cleaved into the active immunomodulatory tetrapeptide tuftsin, initiating sustained downstream neurochemical and gene expression modulation that persists for 24–48 hours)

Origin

n/a

Development Stage

Preclinical / Research Use Only (RUO) in Western jurisdictions; originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and investigated clinically as an anxiolytic and nootropic agent in Russia/CIS

Mechanism

Acts as a synthetic neuropsychotropic heptapeptide that allosterically modulates GABA-A receptor activity and competitively inhibits enkephalin-degrading enzymes (enkephalinases), significantly increasing the biological half-life of endogenous circulating enkephalins. Furthermore, it rapidly stimulates the synthesis and expression of brain-derived neurotrophic factor (BDNF) within the hippocampus and basal forebrain, providing robust anxiolytic, neuroprotective, and nootropic activity without inducing sedation, cognitive impairment, or addiction liability.
Research References
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity
Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission

Advanced Neuropsychotropic, Anxiolytic & BDNF-Modulating Heptapeptide

Investigate the intersection of immunology, neurochemistry, and behavioral science with Selank (10 MG), an elite-tier synthetic heptapeptide engineered for advanced laboratory research into anxiety modulation, cognitive enhancement, and neuroprotection. Originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank is structurally derived from the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg) and strategically elongated at the C-terminus with a three-amino-acid Pro-Gly-Pro motif. This molecular modification dramatically enhances metabolic stability and protects the core peptide pharmacophore against rapid enzymatic degradation.

Unlike classical benzodiazepines that induce sedation, cognitive impairment, and dependency, Selank operates through subtle allosteric modulation of the GABAergic system and the targeted inhibition of enkephalin-degrading enzymes (enkephalinases). This mechanism prolongs the biological half-life of endogenous circulating enkephalins while simultaneously upregulating the synthesis of brain-derived neurotrophic factor (BDNF) within the hippocampus and basal forebrain. It provides researchers with an exceptional biological model for studying stress mitigation, memory formation, and neuro-immune cross-talk without the confounding variables of CNS depression or withdrawal liability.

Key Product Highlights

  • Enkephalinase Inhibition: Competitively blocks enkephalin-degrading enzymes, significantly extending the systemic and localized half-life of natural endogenous enkephalins to study natural stress relief and mood regulation.

  • GABAergic Allosteric Modulation: Modulates GABA-A receptor activity without altering receptor binding affinity, providing an ideal model for investigating anxiolytic pathways without sedation or motor impairment.

  • BDNF Upregulation: Stimulates the expression and synthesis of brain-derived neurotrophic factor (BDNF) in the basal forebrain and hippocampus, facilitating research into neuroplasticity, memory formation, and cognitive repair.

  • Neuro-Immune Bridge: Retains the core immunomodulatory characteristics of its parent peptide, tuftsin, making it a valuable tool for studying the relationship between systemic immune responses and central nervous system function.

  • Non-Sedative & Non-Addictive Profile: Delivers pronounced neuropsychotropic and anti-stress effects without triggering amnesia, withdrawal syndromes, or tolerance buildup.

  • Ultra-Pure Specification: Lyophilized and synthesized at an elite $\ge 99\%$ purity level (HPLC and Mass Spectrometry verified) to ensure absolute precision and flawless reproducibility in complex cellular and behavioral assays.

NOTE

This product is intended for laboratory research use only (RUO). Not for human or veterinary use.

DISCLAIMER

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Peak Vitality peptides have not been approved by Health Canada. Products by Peak Vitality have not been assessed for safety, efficacy and/or quality, may pose a range of serious health risks, and are intended for research purposes only. Products sold under Peak Vitality are not intended to treat, cure, or prevent diseases and/or conditions and may cause serious side effects.

You might also like

Semax 10 MG

$90.00

GHK-Cu (50 MG)

$40.00

NAD+ (500 MG)

$70.00

MOTS-c (10 MG)

$60.00

Elevate Your Performance

Pharmaceutical-grade peptides. Third-party verified. Backed by published research.

Product Categories